Network meta‐analysis and systematic review comparing efficacy and safety between very high power short duration, high power short duration, and conventional radiofrequency ablation of atrial fibrillation
暂无分享,去创建一个
T. Bunch | N. Akoum | R. Ranjan | W. Cheungpasitporn | J. Phannajit | R. Chokesuwattanaskul | J. Kewcharoen | L. Navaravong | N. Tokavanich | N. Prasitlumkum
[1] H. Pürerfellner,et al. Very High-Power Short-Duration (HPSD) Ablation for Pulmonary Vein Isolation: Short and Long-Term Outcome Data , 2022, Journal of cardiovascular development and disease.
[2] M. Christoph,et al. Reconnection patterns after CLOSE‐guided 50 W high‐power‐short‐duration circumferential pulmonary vein isolation and substrate modification—PV reconnection might no longer be an issue , 2022 .
[3] G. Stabile,et al. Safety and efficacy of very high-power short-duration ablation for pulmonary vein isolation , 2022, EP Europace.
[4] B. Merkely,et al. Impact of High-Power and Very High-Power Short-Duration Radiofrequency Ablation on Procedure Characteristics and First-Pass Isolation During Pulmonary Vein Isolation , 2022, Frontiers in Cardiovascular Medicine.
[5] É. Marijon,et al. 90 vs 50-Watt Radiofrequency Applications for Pulmonary Vein Isolation: Experimental and Clinical Findings , 2022, Circulation. Arrhythmia and electrophysiology.
[6] L. Lehmkuhl,et al. Safety aspects of very high power very short duration atrial fibrillation ablation using a modified radiofrequency RF‐generator: Single‐center experience , 2022, Journal of cardiovascular electrophysiology.
[7] P. Maurovich-Horvat,et al. The effect of left atrial wall thickness and pulmonary vein sizes on the acute procedural success of atrial fibrillation ablation , 2022, The International Journal of Cardiovascular Imaging.
[8] Y. Takeishi,et al. Procedural characteristics of pulmonary vein isolation with high-power short-duration setting compared to conventional setting , 2022, BMC Cardiovascular Disorders.
[9] Sean J Dikdan,et al. High-power short-duration versus standard-power standard-duration settings for repeat atrial fibrillation ablation , 2021, Heart and Vessels.
[10] B. Merkely,et al. The role of local impedance drop in the acute lesion efficacy during pulmonary vein isolation performed with a new contact force sensing catheter—A pilot study , 2021, PloS one.
[11] K. Okumura,et al. Ablation Index-Guided High-Power Radiofrequency Application Shortens the Procedure Time With Similar Outcomes to Conventional Power Application in Atrial Fibrillation Ablation , 2021, Circulation reports.
[12] K. Kuck,et al. Very high-power short-duration temperature-controlled ablation versus conventional power-controlled ablation for pulmonary vein isolation: The fast and furious - AF study , 2021, International journal of cardiology. Heart & vasculature.
[13] Seil Oh,et al. Acute and long‐term efficacy of ablation index‐guided higher power shorter duration ablation in patients with atrial fibrillation: A prospective registry , 2021, Journal of arrhythmia.
[14] M. Christoph,et al. Procedural efficacy and safety of standardized, ablation index guided fixed 50 W high‐power short‐duration pulmonary vein isolation and substrate modification using the CLOSE protocol , 2021, Journal of cardiovascular electrophysiology.
[15] Wei-feng Jiang,et al. Meta-analysis of high power short duration in atrial fibrillation ablation – a superior efficient ablation strategy , 2021, Acta cardiologica.
[16] K. Yokoyama,et al. Comparison of In Vivo Tissue Temperature Profile and Lesion Geometry for Radiofrequency Ablation With High Power–Short Duration and Moderate Power–Moderate Duration: Effects of Thermal Latency and Contact Force on Lesion Formation , 2021, Circulation. Arrhythmia and electrophysiology.
[17] P. Nery,et al. High‐power, short‐duration atrial fibrillation ablation compared with a conventional approach: Outcomes and reconnection patterns , 2021, Journal of cardiovascular electrophysiology.
[18] Sean J Dikdan,et al. Comparison of clinical and procedural outcomes between high‐power short‐duration, standard‐power standard‐duration, and temperature‐controlled noncontact force guided ablation for atrial fibrillation , 2021, Journal of cardiovascular electrophysiology.
[19] David D Spragg,et al. Ablation outcomes for atypical atrial flutter versus recurrent atrial fibrillation following index pulmonary vein isolation , 2020, Journal of cardiovascular electrophysiology.
[20] S. Knecht,et al. Prospective Randomized Evaluation of High Power during CLOSE-guided Pulmonary Vein Isolation: The POWER-AF Study. , 2020, Circulation. Arrhythmia and electrophysiology.
[21] Gordon H Guyatt,et al. GRADE approach to drawing conclusions from a network meta-analysis using a minimally contextualised framework , 2020, BMJ.
[22] N. Akoum,et al. High‐power short duration and low‐power long duration in atrial fibrillation ablation: A meta‐analysis , 2020, Journal of cardiovascular electrophysiology.
[23] Lucas Luis Meigre,et al. Changes and impacts in early recurrences after atrial fibrillation ablation in contact force era: comparison of high-power short-duration with conventional technique—FIRST experience data , 2020, Journal of Interventional Cardiac Electrophysiology.
[24] J. Osorio,et al. First pass isolation predicts clinical success after contact force guided paroxysmal atrial fibrillation ablation , 2020 .
[25] Srinivas R. Dukkipati,et al. High‐power short‐duration ablation of atrial fibrillation: A contemporary review , 2020, Pacing and clinical electrophysiology : PACE.
[26] F. Sacher,et al. Temperature and flow controlled ablation/very high-power short-duration ablation vs Conventional power-controlled ablation: Comparison of focal and linear lesion characteristics. , 2020, Heart rhythm.
[27] Hong-Euy Lim,et al. Efficacy of high-power and short-duration ablation in patients with atrial fibrillation: a prospective randomized controlled trial. , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[28] C. Haffajee,et al. Impact of High-Power Short-Duration Radiofrequency Ablation on Long-Term Lesion Durability for Atrial Fibrillation Ablation. , 2020, JACC. Clinical electrophysiology.
[29] M. Shoda,et al. Comparison of high‐power and conventional‐power radiofrequency energy deliveries in pulmonary vein isolation using unipolar signal modification as a local endpoint , 2020, Journal of cardiovascular electrophysiology.
[30] S. Knecht,et al. Evaluation of higher power delivery during RF pulmonary vein isolation using optimized and contiguous lesions , 2020, Journal of cardiovascular electrophysiology.
[31] Shih‐Ann Chen,et al. Atrial Tachycardias After Atrial Fibrillation Ablation: How to Manage? , 2020, Arrhythmia & electrophysiology review.
[32] H. May,et al. Long-term Outcomes After Low Power, Slower Movement versus High Power, Faster Movement Irrigated-Tip Catheter Ablation for Atrial Fibrillation. , 2020, Heart rhythm.
[33] M. Shoda,et al. Impedance drop predicts acute electrical reconnection of the pulmonary vein-left atrium after pulmonary vein isolation using short-duration high-power exposure , 2020, Journal of Interventional Cardiac Electrophysiology.
[34] A. Buxton,et al. Temperature-Controlled Radiofrequency Ablation Using Irrigated Catheters: Maximizing Ventricular Lesion Dimensions While Reducing Steam-Pop Formation. , 2020, JACC. Clinical electrophysiology.
[35] F. Bourier,et al. Safety and outcome of very high-power short-duration ablation using 70 W for pulmonary vein isolation in patients with paroxysmal atrial fibrillation. , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[36] K. Okumura,et al. High‐power application is associated with shorter procedure time and higher rate of first‐pass pulmonary vein isolation in ablation index‐guided atrial fibrillation ablation , 2019, Journal of cardiovascular electrophysiology.
[37] H. Ichiki,et al. Abstract 13136: First-Pass Isolation is Associated With Durability of Pulmonary Vein Isolation and Has Impact on Atrial Fibrillation Ablation Outcomes , 2019 .
[38] J. Merino,et al. Feasibility and safety of pulmonary vein isolation by high-power short-duration radiofrequency application: short-term results of the POWER-FAST PILOT study , 2019, Journal of Interventional Cardiac Electrophysiology.
[39] F. Ruschitzka,et al. Pulmonary vein isolation using a higher power shorter duration CLOSE protocol with a surround flow ablation catheter , 2019, Journal of cardiovascular electrophysiology.
[40] Lucas Luis Meigre,et al. Comparison of high‐power short‐duration (HPSD) ablation of atrial fibrillation using a contact force‐sensing catheter and conventional technique: Initial results , 2019, Journal of cardiovascular electrophysiology.
[41] R. Winkle,et al. Low complication rates using high power (45-50 W) for short duration for atrial fibrillation ablations. , 2019, Heart rhythm.
[42] Nicky J Welton,et al. Automated methods to test connectedness and quantify indirectness of evidence in network meta‐analysis , 2018, Research synthesis methods.
[43] Frederick T. Han,et al. High-Power Radiofrequency Catheter Ablation of Atrial Fibrillation: Using Late Gadolinium Enhancement Magnetic Resonance Imaging as a Novel Index of Esophageal Injury. , 2018, JACC. Clinical electrophysiology.
[44] Spyridon N Papageorgiou,et al. Registration in the international prospective register of systematic reviews (PROSPERO) of systematic review protocols was associated with increased review quality. , 2018, Journal of clinical epidemiology.
[45] Kristian Thorlund,et al. The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations , 2015, Annals of Internal Medicine.
[46] Mohammad Hassan Murad,et al. A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis , 2014, BMJ : British Medical Journal.
[47] Anna Chaimani,et al. Evaluating the Quality of Evidence from a Network Meta-Analysis , 2014, PloS one.
[48] Á. Gil,et al. Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review , 2013, BMC Public Health.
[49] AE Ades,et al. Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies‡ , 2012, Research synthesis methods.
[50] T. Lewalter. [Rhythm---control in atrial fibrillation]. , 2012, MMW Fortschritte der Medizin.
[51] Georgia Salanti,et al. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. , 2011, Journal of clinical epidemiology.
[52] A. Stang. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.
[53] D. Tamborero,et al. Cooled-tip vs. 8 mm-tip catheter for circumferential pulmonary vein ablation: comparison of efficacy, safety, and lesion extension. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[54] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. , 2007, Preventive medicine.
[55] J. Svendsen,et al. The effectiveness of a high output/short duration radiofrequency current application technique in segmental pulmonary vein isolation for atrial fibrillation. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[56] M. Hirai,et al. Can segmental pulmonary vein ablation reduce the recurrence of atrial fibrillation when using a higher RF power, larger tip electrode catheter, and additional RF deliveries?: the limitations of point-by-point RF ablation. , 2006, International heart journal.
[57] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[58] Alex J. Sutton,et al. Evidence Synthesis for Decision Making 2: A Generalized Linear Modeling Framework for Pairwise and Network Meta-analysis of Randomized Controlled Trials. , 2013 .